Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Basil Sharrack"'
Autor:
Tobias Alexander, MD, Noëlle Tassy, PhD(c), Ariadna Domenech, RN, Ellen Kramer, MD, Helen Jessop, RN, Michelle Kenyon, RN, Basil Sharrack, MD, PhD, Riccardo Saccardi, MD, Natacha Bolanos, John A. Snowden, MD, Raffaella Greco, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100283- (2024)
Background: Over the last 3 decades, hematopoietic stem cell transplantation (HSCT) has been successfully used to treat severe and refractory autoimmune diseases (AIDs). A multidisciplinary appraisal of potential benefits and risks by disease and tra
Externí odkaz:
https://doaj.org/article/f4d067f575144cf89a8a3b1ec4e94a03
Autor:
Harriet Moore, Krishnan Padmakumari Sivaraman Nair, Kathleen Baster, Rod Middleton, David Paling, Basil Sharrack
Background\ud \ud Fatigue is a widely experienced, incapacitating symptom of MS. It hinders daily functioning and has deleterious effects on quality of life. The UK MS Register is an online registry of over 20,000 participants with MS. The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7107aed5226245572f87eca95345bdf4
https://cronfa.swan.ac.uk/Record/cronfa61484/Download/61484__25535__7e8a3781b84f43de983cbc2512475e35.pdf
https://cronfa.swan.ac.uk/Record/cronfa61484/Download/61484__25535__7e8a3781b84f43de983cbc2512475e35.pdf
Autor:
Kathleen Quigley, Richard K. Burt, Basil Sharrack, John A. Snowden, Paul Tappenden, Roumen Balabanov, Xiaoqiang Han
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 12 (2021)
Frontiers in Neurology, Vol 12 (2021)
Background: Intravenous immunoglobulin (IVIG) is effective as standard first line therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but some patients remain dependent on its long-term use. Recently, we have reported that a
Autor:
Fiona Roberts, Helen Hobbs, Helen Jessop, Cristina Bozzolini, Joachim Burman, Raffaella Greco, Azza Ismail, Majid Kazmi, Kirill Kirgizov, Gianluigi Mancardi, Susan Mawson, Paolo A. Muraro, Mathieu Puyade, Riccardo Saccardi, Barbara Withers, Bregje Verhoeven, Basil Sharrack, John A. Snowden
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology
Frontiers in Neurology
Autologous haematopoietic stem cell transplantation (AHSCT) is increasingly used to treat people with multiple sclerosis (MS). Supported by an evolving evidence base, AHSCT can suppress active inflammation in the central nervous system and induce lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ab0445047ea4099f6ea8bb839fc440
http://hdl.handle.net/10044/1/90739
http://hdl.handle.net/10044/1/90739
Autor:
Daniel M. Hartung, Kathleen Quigley, Basil Sharrack, Paul Tappenden, Richard K. Burt, John A. Snowden, Indira Arnautovic, Xiaoqiang Han
Publikováno v:
Multiple sclerosis and related disorders. 45
Objective\ud \ud To estimate differences in treatment costs and health outcomes between non-myeloablative hematopoietic stem cell transplantation (HSCT) and disease-modifying therapies (DMTs) for the treatment of relapsing-remitting multiple sclerosi
Autor:
Rachel Harnell, Cara Knight, Lena Palmer, Serena Vanzan, Hannah Carpenter, David Griffths, Rod S Taylor, Kara Crossley, Matthew Foster, Susan Evans, Cris S. Constantinescu, Deborah Fitzsimmons, Laura Hanley, Julia Scott, Miriam Morgan, Natalie Wakefield, Stephen Evans, Amy L. Evans, Shirlee McKeown, Audrey Bowen, Alexandra Erven, Perry Moore, Anita Rose, Olga A Klein, Nadina B. Lincoln, Luke Squires, Avril Drummond, Holly Griffiths, Monica Crone, Claire Isaac, Katie Powers, Brian Barnes, Sophie Keogh, Shannon Gaughan, John Wilson, Jacqueline R Mhizha-Murira, Basil Sharrack, Carolyn A Young, Chris Rumsey, Jo Hobbs, Vera Fixter, Kirsty Sprange, Catherine Edwards, Jenny Freeman, Emma Trigg, Heather Cogger, Helen Oldknow, Alexandra Cunliffe, Gemma Elliot, Sara Clarke, Tracy Tyrell, Shaun Harris, Rory J O’Connor, Alan A Montgomery, Nigel Schofield, Trishna Bharadia, Catherine Pollard, Joanna Dalton, Florence Day, Rona Moss-Morris, Roshan das Nair, Kristy Martin, Stephanie Pegnall, Lucy Bradshaw
Objective: To assess the clinical and cost-effectiveness of cognitive rehabilitation for attention and memory problems in people with multiple sclerosis. Design: Multicentre, pragmatic, randomized controlled trial. Setting: Community Participants: Pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841eb6c2edf6da4a366b3ce3284c921a
https://cronfa.swan.ac.uk/Record/cronfa53016/Download/53016__16648__5395a74195dc4eb8b6a17812a71d6d49.pdf
https://cronfa.swan.ac.uk/Record/cronfa53016/Download/53016__16648__5395a74195dc4eb8b6a17812a71d6d49.pdf
Autor:
Basil Sharrack, Carolyn A Young, Helen Ford, Seema Kalra, Tahir Majeed, Timothy Harrower, Alan Tennant, Helen Santander, R J Mills, David Rog, John Woolmore, Gillian Courtald, Cris S. Constantinescu
Publikováno v:
Journal of the Neurological Sciences. 426:117437
Background and objective Quality of life in multiple sclerosis (MS) reflects complex relationships between symptoms (fatigue, spasticity pain, and bladder or vision dysfunction), disability, health perceptions, and self-efficacy. Methods In this cros
Autor:
Keith Wheatley, Michael A. Burdon, Arul Sivaguru, Andrew S. Jacks, Timothy D Matthews, Alexandra J Sinclair, Basil Sharrack, A. K. Ball, Alexandra Furmston, Andrew Howman, Steven Howell, Mark Lawden, M. Brendan Davies, Carl E Clarke
Publikováno v:
Journal of Neurology. 258:874-881
The cause of idiopathic intracranial hypertension (IIH) remains unknown, and no consensus exists on how patients should be monitored and treated. Acetazolamide is a common treatment but has never been examined in a randomised controlled trial. The ob
Publikováno v:
Journal of the neurological sciences. 354(1-2)
\ud \ud Background Cognitive impairment is a common clinical feature of multiple sclerosis (MS) at both the earlier and later stages of the disease, and has a significant impact on patients' functional status and quality of life. The need to address
Autor:
Andrea K Roalfe, Anouska Carter, Jonathan Tosh, John M. Saxton, Nicola Woodroofe, Basil Sharrack, Nicky Snowdon, Amanda Daley, Jane Petty, Liam Humphreys
Background: Exercise programmes that can demonstrate evidence of long-lasting clinical effectiveness are needed for people with multiple sclerosis (P wMS). Objective: The objective of this study was to assess the effects of a practically implemented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b821b061758d70a622f4caef7a3c37a2